On the impact of the CYP2D6 ultra-rapid metabolizer genotype on mirtazapine pharmacokinetics.

被引：0
|
作者：
Brockmöller, J
Kirchheiner, J
Henckel, H
Meineke, I
Roots, I
机构：
[1] Univ Gottingen, D-3400 Gottingen, Germany
[2] Humboldt Univ, D-1086 Berlin, Germany
[3] Charite Med Ctr, Berlin, Germany
来源：
CLINICAL PHARMACOLOGY & THERAPEUTICS | 2004年 / 75卷 / 02期
关键词：
D O I：
10.1016/j.clpt.2003.11.250
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：P67 / P67
页数：1
相关论文
共 50 条
  • [31] Is CYP2D6 phenotype predictable from CYP2D6 genotype?
    Kiss, Adam Ferenc
    Toth, Katalin
    Juhasz, Cintia
    Temesvari, Manna
    Paulik, Jozsef
    Hirka, Gabor
    Monostory, Katalin
    MICROCHEMICAL JOURNAL, 2018, 136 : 209 - 214
  • [32] CYP2D6*36 gene arrangements within the CYP2D6 locus:: Association of CYP2D6*36 with poor metabolizer status
    Gaedigk, A
    Bradford, LD
    Alander, SW
    Leeder, JS
    DRUG METABOLISM AND DISPOSITION, 2006, 34 (04) : 563 - 569
  • [33] Rapid detection of the ultraextensive metabolizer associated CYP2D6*35 polymorphism.
    Steimer, W
    Bachofer, J
    Leucht, S
    Müller, B
    CLINICAL CHEMISTRY, 2002, 48 (06) : A45 - A45
  • [34] CYP2D6 genotype and risperidone pharmacokinetics, pharmacodynamics and side effects
    Novalbos, J.
    Lopez-Rodriguez, R.
    Roman, M.
    PHARMACOGENOMICS, 2011, 12 (03) : 312 - 312
  • [35] Pharmacokinetics of diltiazem and its metabolites in relation to CYP2D6 genotype
    Molden, E
    Johansen, PW
    Boe, GH
    Bergan, S
    Christensen, H
    Rugstad, HE
    Rootwelt, H
    Reubsaet, L
    Lehne, G
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2002, 72 (03) : 333 - 342
  • [36] EFFECT OF PAROXETINE ON THE PHARMACOKINETICS OF ATOMOXETINE IN DIFFERENT CYP2D6 GENOTYPE
    Kim, S. H.
    Byeon, J. Y.
    Kim, Y. H.
    Lee, H. J.
    Lee, Y.
    Lee, Y. J.
    Kim, D. H.
    Lim, H. J.
    Lee, S. Y.
    CLINICAL THERAPEUTICS, 2015, 37 (08) : E60 - E60
  • [37] CYP2D6 metabolizer status and postoperative analgesia with tramadol
    Wilder-Smith, CH
    Wilkins, J
    ANESTHESIOLOGY, 1999, 91 (3A) : U416 - U416
  • [38] Impact of CYP2D6 Genotype on Paroxetine Serum Concentration
    Hole, Kristine
    Haslemo, Tore
    Molden, Espen
    THERAPEUTIC DRUG MONITORING, 2023, 45 (05) : 683 - 688
  • [39] Impact of CYP2D6 genotype on postoperative tramadol analgesia
    Stamer, UM
    Lehnen, K
    Höthker, F
    Bayerer, B
    Wolf, S
    Hoeft, A
    Stuber, F
    PAIN, 2003, 105 (1-2) : 231 - 238
  • [40] Influence of sex and CYP2D6 genotype on mirtazapine disposition, evaluated in Spanish healthy volunteers
    Borobia, Alberto M.
    Novalbos, Jesus
    Guerra-Lopez, Pedro
    Lopez-Rodriguez, Rosario
    Tabares, Beatriz
    Rodriguez, Vanesa
    Abad-Santos, Francisco
    Carcas, Antonio J.
    PHARMACOLOGICAL RESEARCH, 2009, 59 (06) : 393 - 398
12345